Stock Earnings

Question 1

Quels sont les états financiers clés de AbbVie Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), AbbVie Inc a un total d'actifs de $135,161, un bénéfice net profit de $4,238

Question 2

Quels sont les ratios financiers clés pour ABBV ?

Accepted Answer

Le ratio de liquidité de AbbVie Inc est 1.02, la marge nette est 7.52, les ventes par action sont de $31.77.

Question 3

Comment les revenus de AbbVie Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

AbbVie Inc largest revenue segment is Immunology, at a revenue of 26,682,000,000 in the most earnings release.For geography, United States is the primary market for AbbVie Inc, at a revenue of 43,029,000,000.

Question 4

AbbVie Inc est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, AbbVie Inc a un bénéfice net profit de $4,238

Question 5

AbbVie Inc a-t-elle des passifs ?

Accepted Answer

yes, AbbVie Inc a un passif de 131,836

Question 6

Combien d'actions en circulation AbbVie Inc a-t-elle ?

Accepted Answer

AbbVie Inc a un total d'actions en circulation de 1,765.25

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	58,328	56,334	54,318	58,054	56,197	45,804
Revenue Growth (YoY)	6%	4%	-6%	3%	23%	38%
Cost of Revenue	16,956	16,904	18,226	16,527	17,314	15,257
Gross Profit	41,372	39,430	36,092	41,527	38,883	30,547
Selling, General & Admin	14,562	14,649	12,680	14,861	11,996	10,674
Research & Development	8,602	8,291	7,038	6,487	6,982	6,181
Operating Expenses	23,133	22,933	19,539	21,404	19,410	16,855
Other Non Operating Income (Expenses)	-5,389	-3,240	-4,677	-2,448	-2,500	-5,614
Pretax Income	3,030	3,716	6,250	13,477	12,989	3,398
Income Tax Expense	-741	-570	1,377	1,632	1,440	-1,224
Net Income	3,723	4,238	4,820	11,782	11,468	4,556
Net Income Growth	-30%	-12%	-59%	3%	152%	-42%
Shares Outstanding (Diluted)	1,771	1,773	1,773	1,778	1,777	1,673
Shares Change (YoY)	0%	0%	0%	0%	6%	13%
EPS (Diluted)	2.1	2.39	2.72	6.63	6.45	2.72
EPS Growth	-30%	-12%	-59%	3%	137%	-48%
Free Cash Flow	18,239	17,832	22,062	24,248	21,990	16,790
Free Cash Flow Per Share	10.29	10.05	12.44	13.63	12.37	10.03
Gross Margin	70.92%	69.99%	66.44%	71.53%	69.19%	66.69%
Operating Margin	31.26%	29.28%	30.47%	34.66%	34.65%	29.89%
Profit Margin	6.38%	7.52%	8.87%	20.29%	20.4%	9.94%
Free Cash Flow Margin	31.26%	31.65%	40.61%	41.76%	39.13%	36.65%
EBITDA	26,509	24,883	25,251	28,590	27,994	20,163
EBITDA Margin	45.44%	44.17%	46.48%	49.24%	49.81%	44.02%
D&A For EBITDA	8,270	8,386	8,698	8,467	8,521	6,471
EBIT	18,239	16,497	16,553	20,123	19,473	13,692
EBIT Margin	31.26%	29.28%	30.47%	34.66%	34.65%	29.89%
Effective Tax Rate	-24.45%	-15.33%	22.03%	12.1%	11.08%	-36.02%

AbbVie Inc (ABBV) Price

ABBV Stock Price Chart

ABBV Income

Follow-Up Questions